Ownership history in FOX RUN MANAGEMENT, L.L.C. · 8 quarters on record
This page tracks every 13F SEC filing in which FOX RUN MANAGEMENT, L.L.C. reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 27,223 | +13,256 | +94.9% | 0.10% | $616K | $22.63 |
| 2025 Q2 | REDUCED | 13,967 | -1,745 | -11.1% | 0.04% | $242K | $17.31 |
| 2025 Q1 | REDUCED | 15,712 | -6,390 | -28.9% | 0.05% | $344K | $21.87 |
| 2024 Q2 | ADDED | 22,102 | +16,867 | +322.2% | 0.16% | $848K | $38.36 |
| 2023 Q4 | REDUCED | 5,235 | -1,198 | -18.6% | 0.08% | $313K | $59.86 |
| 2023 Q3 | ADDED | 6,433 | +4,136 | +180.1% | 0.07% | $245K | $38.04 |
| 2023 Q2 | REDUCED | 2,297 | -8,522 | -78.8% | 0.06% | $209K | $91.10 |
| 2022 Q3 | INITIATED | 10,819 | — | — | 0.29% | $739K | $68.30 |
As of 2025 Q4 — sorted by position size